| Literature DB >> 27054171 |
Rubén Gómez-Sánchez1, Sokhna M S Yakhine-Diop2, Mario Rodríguez-Arribas2, José M Bravo-San Pedro3, Guadalupe Martínez-Chacón2, Elisabet Uribe-Carretero2, Diana C J Pinheiro de Castro2, Elisa Pizarro-Estrella2, José M Fuentes2, Rosa A González-Polo2.
Abstract
We characterized the dynamics of autophagy in vitro using four different cell systems and analyzing markers widely used in this field, i.e. LC3 (microtubule-associated protein 1 light chain 3; protein recruited from the cytosol (LC3-I) to the autophagosomal membrane where it is lipidated (LC3-II)) and p62/SQSTM1 (adaptor protein that serves as a link between LC3 and ubiquitinated substrates), (Klionsky et al., 2016) [1]. Data provided include analyses of protein levels of LC3 and p62 by Western-blotting and endogenous immunofluorescence experiments, but also p62 mRNA levels obtained by quantitative PCR (qPCR). To monitor the turnover of these autophagy markers and, thus, measure the flux of this pathway, cells were under starvation conditions and/or treated with bafilomycin A1 (Baf. A1) to block fusion of autophagosomes with lysosomes.Entities:
Keywords: Autophagy; Baf. A1, Bafilomycin A1; EBSS, Earle׳s Balanced Salt Solution; FBS, Fetal bovine serum; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; HFs, Human fibroblasts; LC3; LC3, Microtubule-associated protein 1 light chain 3; MEFs, Mouse embryonic fibroblasts; PBS, Phosphate-buffered saline; SB, Sample buffer; SDS, Sodium dodecyl sulfate; TBST, Tris-buffered saline with Tween 20; Western-blot; p62; qPCR, Quantitative PCR
Year: 2016 PMID: 27054171 PMCID: PMC4802425 DOI: 10.1016/j.dib.2016.02.085
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1LC3 and p62 modulation after EBSS±Baf. A1 treatment in four cell models. Cells were treated with EBSS, Baf. A1 and dual treatment for 4 h, as described in Section 2. Representative blots of 3 independent experiments of MEFs (A), HFs (D) SH-SY5Y (G) and N27 rat dopaminergic cells (J) are shown. GAPDH was used as a loading control. p62 densitometry expressed in arbitrary units is shown in panels B (MEFs), E (HFs), H (SH-SY5Y) and K (N27). LC3 (isoforms I and II) densitometry expressed in arbitrary units is shown in panels C (MEFs), F (HFs), I (SH-SY5Y) and L (N27). Data represent the mean±SEM; n=3 (*p≤0.05, **p≤0.01, ***p≤0.001, related to the corresponding non-treated condition).
Fig. 2Endogenous immunofluorescence of LC3 and p62 after EBSS ± Baf. A1 treatment in four cell models. Cells were treated with EBSS, Baf. A1 and dual treatment for 4 h, as described in Section 2. Representative images from MEFs (A), HFs (C), SH-SY5Y (E) and N27 cells (G) are shown. Scale bars equate to 10 µm. Histograms show quantification of fluorescence intensity per cell from MEFs (B), HFs (D), SH-SY5Y (F) and N27 cells (H). Data represent the mean±SEM; n=3 (*p≤0.05, **p≤0.01, related to the corresponding non-treated condition).
Fig. 3p62 mRNA analysis after EBSS±Baf. A1 treatment in four cell models. Cells were treated with EBSS, Baf. A1 and dual treatment for 4 h, as described below. Quantification of p62 mRNA expression levels from all lines studied is shown: MEFs (A), HFs (B), SH-SY5Y (C) and N27 cells (D). Relative expression was determined using GAPDH as a housekeeping gene. Data represent the mean±SEM; n=3 (**p≤0.01, related to the corresponding non-treated condition).
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |